Oxygenta Pharmaceutical Limited (BOM:524636)
49.86
-0.74 (-1.46%)
At close: Mar 9, 2026
Oxygenta Pharmaceutical Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Net Income | - | -96.83 | -34.79 | -115.71 | -6.1 | 29.3 | Upgrade
|
| Depreciation & Amortization | - | 8.16 | 26.61 | 20.52 | 15.91 | 11.96 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 7.72 | - | - | - | - | Upgrade
|
| Other Operating Activities | - | -11.31 | -87.45 | 16.81 | 9.2 | 17.6 | Upgrade
|
| Change in Accounts Receivable | - | 11.8 | 31.96 | -85.84 | 0.34 | -11.87 | Upgrade
|
| Change in Inventory | - | -67.97 | -20.11 | -44.22 | 48.31 | -78.61 | Upgrade
|
| Change in Accounts Payable | - | 69.07 | -39.57 | 212.07 | -90.94 | 80.4 | Upgrade
|
| Change in Other Net Operating Assets | - | 105.39 | -7.13 | -19.96 | 6.48 | -65 | Upgrade
|
| Operating Cash Flow | - | 26.03 | -130.5 | -16.34 | -16.8 | -16.22 | Upgrade
|
| Capital Expenditures | - | -113.92 | -41.06 | -96.45 | -49.46 | -67.41 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 1.2 | - | - | - | - | Upgrade
|
| Other Investing Activities | - | 0.22 | 0.18 | 0.05 | 0.04 | 0.23 | Upgrade
|
| Investing Cash Flow | - | -112.49 | -40.88 | -96.4 | -49.41 | -67.19 | Upgrade
|
| Short-Term Debt Issued | - | 324.78 | - | - | - | - | Upgrade
|
| Long-Term Debt Issued | - | - | - | 127.12 | 32.57 | 104.5 | Upgrade
|
| Total Debt Issued | - | 324.78 | - | 127.12 | 32.57 | 104.5 | Upgrade
|
| Long-Term Debt Repaid | - | -274.79 | -107.6 | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | - | 49.99 | -107.6 | 127.12 | 32.57 | 104.5 | Upgrade
|
| Issuance of Common Stock | - | 54.5 | 289.23 | - | 40 | - | Upgrade
|
| Other Financing Activities | - | -17.82 | -10.32 | -14.88 | -9.25 | -17.83 | Upgrade
|
| Financing Cash Flow | - | 86.67 | 171.32 | 112.24 | 63.32 | 86.67 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | 0 | - | - | 0 | -0 | Upgrade
|
| Net Cash Flow | - | 0.21 | -0.05 | -0.5 | -2.89 | 3.27 | Upgrade
|
| Free Cash Flow | - | -87.89 | -171.55 | -112.79 | -66.26 | -83.63 | Upgrade
|
| Free Cash Flow Margin | - | -8.04% | -43.28% | -36.40% | -10.95% | -16.07% | Upgrade
|
| Free Cash Flow Per Share | - | -2.44 | -5.35 | -7.94 | -5.20 | -6.56 | Upgrade
|
| Cash Interest Paid | - | 17.82 | 15.94 | 14.88 | 9.25 | 17.83 | Upgrade
|
| Cash Income Tax Paid | - | 1.6 | - | - | - | - | Upgrade
|
| Levered Free Cash Flow | - | -54.68 | -110.47 | -95.62 | -55.73 | -146.96 | Upgrade
|
| Unlevered Free Cash Flow | - | -42.07 | -100.59 | -86.4 | -50.01 | -135.86 | Upgrade
|
| Change in Working Capital | - | 118.29 | -34.86 | 62.05 | -35.81 | -75.08 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.